成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
Hi!歡迎來到ChemicalBook
登錄
注冊(cè)
熱線電話:400-158-6606
行業(yè)精選
我的ChemicalBook
發(fā)布產(chǎn)品
產(chǎn)品管理
發(fā)布供應(yīng)信息
黃金產(chǎn)品設(shè)置
大貨產(chǎn)品設(shè)置
直通車產(chǎn)品設(shè)置
∨
發(fā)布供應(yīng)信息
產(chǎn)品
求購信息
供應(yīng)信息
化工站點(diǎn)
結(jié)構(gòu)式搜索
采購清單
網(wǎng)站主頁
化工產(chǎn)品目錄
生物化工
抑制劑
細(xì)胞周期(Cell Cycle)
CDK 抑制劑
細(xì)胞周期蛋白B激酶抑制劑
化合物 Roscovitine
化合物 Roscovitine|T2095
價(jià)格
¥
415
¥
734
¥
995
包裝
5mg
10mg
25mg
最小起訂量
1mg
發(fā)貨地
上海
更新日期
2024-09-14
QQ交談
微信洽談
產(chǎn)品詳情
中文名稱:
化合物 Roscovitine
英文名稱:
Seliciclib
CAS:
186692-46-6
品牌:
TargetMol
產(chǎn)地:
美國
保存條件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
純度規(guī)格:
99.88%
產(chǎn)品類別:
抑制劑
貨號(hào):
T2095
2024-09-14
化合物 Roscovitine
Seliciclib
5mg/415RMB;10mg/734RMB;25mg/995RMB
415
TargetMol
美國
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
99.88%
抑制劑
Product Introduction
Bioactivity
名稱
Seliciclib
描述
Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E (IC50=0.1 μM). Seliciclib also inhibits Cdk7/cyclin H, Cdk5/p35 and Cdc2/cyclin B (IC50=0.49/0.16/0.65 μM). Seliciclib has antitumor activity.
細(xì)胞實(shí)驗(yàn)
L1210 cells taken from exponentially growing cultures in RPMT-1640 medium supplemented with 10% foetal calf serum, penicillin and streptomycin, were counted using a hemocytometer, seeded at 5X10^4 cells/ml in tissue-culture 96-wells plates in the presence or absence of various concentrations of roscovitine or olomoucine and incubated at 37°C under 5% CO,. For reversion of the roscovitine effect, L1210 cells cultured two days in the presence or absence of roscovitine were washed in phosphate-buffered saline to remove any trace of the drug, counted and reseeded in fresh medium containing no drug. Cell growth was monitored daily using the microculture tetrazolium assay. Cell cycle analysis was performed on cells that were fixed in ethanol, treated with 100 μg/ml RNase and stained with propidium iodide. We used a Coulter EPICS Elite flow cytometer for acquisition and the Multicycle software for analysis of the data. All assays were performed in triplicate and experiments repeated at least twice [1].
激酶實(shí)驗(yàn)
Kinases activities were assayed at 30°C in buffer C (unless otherwise specified). Blank values were substracted from the data and activities calculated as the molar amount of phosphate incorporated in protein acceptor during a 10-min incubation. Controls were performed with appropriate dilutions of Me2SO. In a few cases, phosphorylation of the substrate was assessed by autoradiography after SDS/PAGE [1].
動(dòng)物實(shí)驗(yàn)
Male athymic nude mice (5-6 weeks old) were obtained from the National Cancer Institute. Mice were housed in the animal facilities of the Georgetown University Division of Comparative Medicine. All animal work was done under protocols approved by the Georgetown University Animal Care and Use Committee. Mice were inoculated s.c. into the right posterior flank with 4 × 10^6 A4573 cells in 100 μL of Matrigel basement membrane matrix. Xenografts were grown to a mean tumor volume of 129 ± 30 mm^3. Roscovitine was first dissolved in either absolute methanol or DMSO (1 volume). A carrier solution was produced by using a diluent containing 10% Tween 80, 20% N-N-dimethylacetamide, and 70% polyethylene glycol 400. Mice were randomized into two groups (six animals per group) and treatment was initiated. One group was treated with roscovitine, administered as a single daily i.p. injection, at a dose of 50 mg/kg, for either 5 days or two 5-day series with a 2-day break in between. The control group received i.p. injections of the carrier solution following identical schedules. All mice were sacrificed by asphyxiation with CO2. Roscovitine-treated mice were euthanized either 7 days after the first injection or up to 4 weeks after completion of the treatment. At those times, tumors were removed, measured, and prepared for TUNEL assays. Primary tumor volumes were calculated by the formula V = (1/2)a × b2, where a is the longest tumor axis and b is the shortest tumor axis. Data are given as mean values ± SE in quantitative experiments. Statistical analysis of differences between groups was done by a one-way ANOVA followed by an unpaired Student's t-test [4].
體外活性
方法
: MM 細(xì)胞系 MM.1S、OPM2、RPMI、U266、Dox-40、LR5、MM1.R 用 Seliciclib (10-100 μM) 處理 24 h,通過 MTT assay 檢測(cè)細(xì)胞活力。
結(jié)果
: Seliciclib 在 24 h 內(nèi)產(chǎn)生劑量依賴性細(xì)胞毒性,IC50 范圍為 15-25 μM。[1]
方法
: 套細(xì)胞淋巴瘤 (MCL) 細(xì)胞 Granta-519、NCEB-1、REC-1 和 JeKo-1 用 Seliciclib (25-50 μM) 處理 24-48 h,通過 Flow cytometry 檢測(cè)細(xì)胞周期。
結(jié)果
: 用 IC50 劑量的 Seliciclib 處理 24 h 后,Granta-519、NCEB-1 和 REC-1 細(xì)胞中檢測(cè)到 G2-M 期細(xì)胞的積聚,與對(duì)照組相比,JeKo-1 細(xì)胞在 48 h 時(shí)檢測(cè)到細(xì)胞的積聚。用 Seliciclib 處理 24 和 48 h 后,除 Granta-519 外,所有細(xì)胞的 sub-G1 峰都明顯增加,表明細(xì)胞凋亡。[2]
體內(nèi)活性
方法
: 為檢測(cè)體內(nèi)抗腫瘤活性,將 Seliciclib (300 mg/kg/d) 在 Zeitgeber 時(shí)間 (ZT) 3、11 或 19 口服給藥給攜帶 Glasgow 骨肉瘤的 B6D2F1 小鼠,持續(xù) 5 天。
結(jié)果
: 與對(duì)照組相比,Seliciclib 在 ZT3 或 ZT11 給藥后將腫瘤生長減少了 55%,在 ZT19 給藥后減少了 35%。[3]
存儲(chǔ)條件
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 50 mg/mL (141.06 mM)
Ethanol : 6 mg/mL (16.92 mM)
關(guān)鍵字
CYC-202 | inhibit | CYC 202 | Seliciclib | Inhibitor | Cyclin dependent kinase | CDK
相關(guān)產(chǎn)品
Sodium Oxamate | Ribociclib | Palbociclib monohydrochloride | Abemaciclib methanesulfonate | CASIN | Olomoucine | Palbociclib | GW 441756 | Dinaciclib | Ro-3306 | GSK 3 Inhibitor IX | Abemaciclib
相關(guān)庫
抑制劑庫 | 抗癌活性化合物庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 激酶抑制劑庫 | 抗衰老化合物庫 | 藥物功能重定位化合物庫 | 抗癌臨床化合物庫 | 表型篩選靶點(diǎn)鑒定庫 | 抗癌藥物庫
關(guān)鍵字:
Roscovitine|||R-roscovitine|||CYC202|TargetMol
公司簡(jiǎn)介
上海陶術(shù)生物科技有限公司為美國Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國波士頓、德國慕尼黑的同事一起,為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部,化學(xué)事業(yè)部,生物事業(yè)部和新材料部。 從虛擬篩選到實(shí)體化合物分子供應(yīng);從商業(yè)化產(chǎn)品銷售到個(gè)性化定制合成;從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選,從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化,我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。 經(jīng)過在中國市場(chǎng)五年的精心耕耘,我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商,為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩
成立日期
2013-04-18
(12年)
注冊(cè)資本
566.2651萬人民幣
員工人數(shù)
100-500人
年?duì)I業(yè)額
¥ 1億以上
主營行業(yè)
化學(xué)試劑,生物活性小分子
經(jīng)營模式
貿(mào)易,試劑,定制,服務(wù)
TargetMol中國(陶術(shù)生物)
VIP
12年
公司成立:
12年
注冊(cè)資本:
566.2651萬人民幣
企業(yè)類型:
有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品:
小分子抑制劑,藥物篩選化合物庫,天然產(chǎn)物,活性分子化合物等
公司地址:
上海市閘北區(qū)江場(chǎng)三路28號(hào)4樓
進(jìn)入店鋪
詢盤
店內(nèi)推薦
靶點(diǎn)化合物庫
¥5000
篩選化合物庫
¥100000
化合物 CI994|T1888
¥198
化合物 Roscovitine|T2095相關(guān)廠家報(bào)價(jià)
更多
產(chǎn)品名稱
價(jià)格
公司名稱
報(bào)價(jià)日期
CDK抑制劑(Roscovitine)
詢價(jià)
VIP
5年
上海澤葉生物科技有限公司
2024-10-31
Roscovitine;
詢價(jià)
VIP
4年
湖北諾迪納生物技術(shù)有限公司
2024-10-21
Roscovitine (Seliciclib)
詢價(jià)
南京百鑫德諾生物科技有限公司
2024-09-26
Roscovitine;
詢價(jià)
VIP
5年
湖北惠擇普醫(yī)藥科技有限公司
2024-09-24
aladdin 阿拉丁 R125384 Roscovitine (Seliciclib,CYC202) 186692-46-6 ≥98%
¥2560.90
VIP
1年
上海阿拉丁生化科技股份有限公司
2024-08-16
核抑制劑
詢價(jià)
VIP
2年
陜西西化化學(xué)工業(yè)有限公司
2024-07-24
Roscovitine (Seliciclib)|CDKs抑制劑|Adooq
詢價(jià)
南京百鑫德諾生物科技有限公司
2024-09-26
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁
|
企業(yè)會(huì)員服務(wù)
|
廣告業(yè)務(wù)
|
聯(lián)系我們
|
舊版入口
|
中文MSDS
|
CAS Index
|
常用化學(xué)品CAS列表
|
化工產(chǎn)品目錄
|
新產(chǎn)品列表
|
投訴中心
Copyright ? 2008 ChemicalBook
京ICP備07040585號(hào)
京公海網(wǎng)安備110108000080號(hào) All rights reserved.
400-158-6606
TargetMol中國(陶術(shù)生物)
聯(lián)系人:
邵小姐
電話:
021-021-33632979
手機(jī):
15002134094
郵箱:
marketing@targetmol.com
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
產(chǎn)品咨詢